Announcements Trials
Browse Landscape

Phase

Phase 2 91Phase NA 53Phase 1 45Phase 1/2 26Phase 3 24Phase EARLY_PHASE1 4Phase 4 4Phase 2/3 3

Status

Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1

Conditions

Glioblastoma 17Glioma 15Breast Neoplasms 14Prostatic Neoplasms 13Neoplasms 13Brain Neoplasms 11Pancreatic Neoplasms 10Colorectal Neoplasms 10Neoplasm Metastasis 9Multiple Myeloma 8Lymphoma, B-Cell 8Recurrence 7Melanoma 7Lymphoma 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Head and Neck Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Lung Neoplasms 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3

Interventions

semaglutide 1peginterferon alfa-2b 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Hepatocellular × 90 days × Clear all
NCT07627191 2026-06-04

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

University of Arizona

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Colorectal Neoplasms

NCT06653023 2026-05-07

Wondercel-UWD3

Wondercel Biotech (ShenZhen)

Phase EARLY_PHASE1 Suspended
60 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular

NCT07553767 2026-04-28

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

Ningbo No.2 Hospital

Phase EARLY_PHASE1 Not yet recruiting
156 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT07487402 2026-04-21

Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma

Zhejiang University

Phase EARLY_PHASE1 Not yet recruiting
27 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡